BETHANY STERN: Open Payments
NPI 1801331152 · HAZELWOOD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 29 payments from 11 companies in 2025. Trend: 2023 $395 · 2024 $547 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $202 |
| TOLMAR, INC. | 3 | $74 |
| ABBVIE INC. | 3 | $64 |
| Ascendis Pharma Endocrinology Inc | 3 | $61 |
| ALK-Abello, Inc | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Amphastar Pharmaceuticals, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
Products named: Wegovy, FENSOLVI, LUPRON DEPOT, Skytrofa, NEFFY, CRENESSITY, t:slim X2 Insulin Pump with Control-IQ, ROTATEQ.
Industry payments across MO — which companies pay providers there.
